New York State Common Retirement Fund Iveric Bio, Inc. Transaction History

New York State Common Retirement Fund

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 07, 2023	SELL	$26.24 - $39.63 $721,521 - $1.09 Million	-27,497 Reduced 33.22%	55,264 $2.17 Million
Q1 2023 May 02, 2023	SELL	$18.67 - $24.56 $1.31 Million - $1.72 Million	-70,056 Reduced 45.84%	82,761 $2.01 Million
Q4 2022 Jan 30, 2023	BUY	$17.24 - $23.95 $1.2 Million - $1.67 Million	69,895 Added 84.29%	152,817 $3.27 Million
Q3 2022 Nov 08, 2022	SELL	$9.4 - $18.59 $319,158 - $631,186	-33,953 Reduced 29.05%	82,922 $1.49 Million
Q2 2022 Aug 04, 2022	SELL	$9.12 - $18.9 $132,176 - $273,917	-14,493 Reduced 11.03%	116,875 $1.12 Million
Q1 2022 May 05, 2022	BUY	$12.15 - $16.83 $692,452 - $959,175	56,992 Added 76.63%	131,368 $2.21 Million
Q4 2021 Feb 02, 2022	BUY	$13.83 - $18.78 $90,116 - $122,370	6,516 Added 9.6%	74,376 $1.24 Million
Q3 2021 Nov 02, 2021	SELL	$7.07 - $17.5 $73,549 - $182,052	-10,403 Reduced 13.29%	67,860 $1.1 Million
Q2 2021 Aug 02, 2021	BUY	$5.69 - $7.17 $107,330 - $135,247	18,863 Added 31.76%	78,263 $494,000
Q4 2020 Feb 08, 2021	BUY	$5.65 - $7.66 $102,830 - $139,412	18,200 Added 44.17%	59,400 $410,000
Q2 2020 Aug 07, 2020	BUY	$3.06 - $6.6 $126,072 - $271,920	41,200 New	41,200 $210,000

250K

40K

Ticker ISEE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 118,078,000
Description
IVERIC bio, Inc., a biopharmaceutical company, discovers and develops novel treatments for retinal diseases with a focus on age-related and orphan inherited retinal diseases (IRDs). The company develops Zimura, an inhibitor of complement factor C5 comprising GATHER1, which has completed Phase 2/3 clinical trial; and GATHER2 that is in Phase 3 cl...

Get notified when there are updates to the investment portfolio of New York State Common Retirement Fund, based on Form 13F filings with the SEC.

Stay updated on New York State Common Retirement Fund with notifications on news.